How many companies have PKD 21.10.Z?

The primary industry for 314 companies is manufacture of basic pharmaceutical products. 88 entities have filed financial statements.

How many new companies were registered in 2026?

So far in 2026, 4 new companies with PKD 21.10.Z have been registered. In all of 2025, there were 6 such companies.

How many companies were deregistered in 2026?

So far in 2026, 1 company with PKD 21.10.Z have been deregistered. In all of 2025, there were 10 such companies.

What revenue do companies in this industry generate?

In 2025, the median revenue for PKD 21.10.Z was USD 168.16k and the mean revenue was USD 3.04m, based on 48 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.

Are companies with PKD 21.10.Z profitable?

Yes, in 2025, the median net profit was USD 7.40k, an improvement on 2024 (USD 1.17k). Among all 674 industries in Poland, PKD 21.10.Z ranks 596th, placing it among the weakest 12%.

What legal form do companies in this industry take?

The most common legal form for PKD 21.10.Z is sp. z o.o., used by 211 companies in this industry (67.2% of the total). In second place is sp. j. (44 companies, 14.0%), and in third place – a sole proprietorship (22 companies, 7.0%).

Manufacture of basic pharmaceutical products (PKD 21.10.Z)

This subclass includes:

the production of active pharmaceutical ingredients used in the manufacture of pharmaceutical products (for example antibiotics, basic vitamins, salicylic acid, aspirin),
blood processing,
the production of chemically pure sugars,
the production of probiotics,
gland processing,
the production of gland extracts.

This subclass excludes:

the production of pharmaceutical products for advanced cell and gene therapy, classified in 21.20.Z.

Industry statistics (2025)

Number of companies

Companies

4,896

Companies (primary PKD)

314

Companies with financials

Business turnover

Legal structure

Legal formShare of companiesNumber of companies

Sp. z o.o.67.2%211
Sp. j.14.0%44
JDG7.0%22
S.A.4.8%15
Sp. k.3.8%12
Other1.0%3
P.S.A.0.6%2
Cooperative0.6%2

Financial results

Median revenue

Ranking

Median revenue compared with other PKD codes.

Top companies by revenue

#	Company	Legal form	Revenue	Net profit
1	Farmak International	sp. z o.o.	USD 101.19m	USD 5.85m
2	Vitasynth	sp. z o.o.	USD 7.35m	USD 2.38m
3	Biotee Polska	sp. z o.o.	USD 5.51m	USD 662.57k
4	Centrum Medyczne Medicos	S.A.	USD 4.69m	USD 873.80k
5	Ju&Mi Junczyk I Miszkurka	sp. j.	USD 4.14m	USD 141.39k
6	Aurora Polska	sp. z o.o.	USD 2.24m	USD 98.73k
7	Biopharmacotech	sp. z o.o.	USD 2.19m	USD -1.86m
8	Przedsiębiorstwo Produkcyjno-Usługowo-Handlowe Hydromax	sp. z o.o.	USD 2.04m	USD 8.52k
9	L-Amino Plus	sp. z o.o.	USD 1.97m	USD 134.27k
10	Probiome	sp. z o.o.	USD 1.80m	USD 218.61k

Fastest-growing companies

#	Company	Legal form	Revenue	Y/Y growth
1	Probiome	sp. z o.o.	USD 1.80m	+530.7% y/y
2	Farmak International	sp. z o.o.	USD 101.19m	+333.1% y/y
3	Vitasynth	sp. z o.o.	USD 7.35m	+80.7% y/y
4	L-Amino Plus	sp. z o.o.	USD 1.97m	+50.5% y/y
5	TRZY Stawy	sp. z o.o.	USD 757.63k	+36.8% y/y
6	Alpha Pharmaceutical	sp. z o.o.	USD 906.74k	+14.8% y/y
7	Millenium Farmacja	sp. z o.o.	USD 1.03m	+14.1% y/y
8	Nucmed	sp. z o.o.	USD 1.71m	+13.0% y/y
9	Ju&Mi Junczyk I Miszkurka	sp. j.	USD 4.14m	+10.4% y/y
10	J.J.B. Omega	sp. z o.o.	USD 414.89k	+8.8% y/y

Stock market

No companies from this industry are listed.

Related PKD codes in division 21


21.20.Z	Manufacture of pharmaceutical preparations	8,157